Disputed Liability and Pharmacy Lien: How Medications Continued Despite Insurance Denial

James Wong — Founder & Pharmacist, LienScripts | February 10, 2026 | 9 min read

When both drivers disputed fault after an intersection collision and neither insurer would accept liability, a pharmacy lien kept the injured patient on essential medications throughout the litigation — until a 70/30 settlement resolved the standoff.

Case Background

Note: This is a fictionalized case study based on composite facts. Names and identifying details are not real. The clinical details represent typical medication patterns for this injury type.

Maria, 41, was driving through a four-way intersection on her way to work when a pickup truck ran the opposing stop sign and struck her vehicle on the driver's side. The impact was significant — her car was pushed into the adjacent lane and required towing. Maria was transported by ambulance to the emergency department with complaints of neck pain, left shoulder pain, and a headache that would persist for weeks.

The emergency physicians documented soft tissue injuries, a suspected mild concussion, and ordered imaging that revealed a C5-C6 disc protrusion. Maria was discharged with prescriptions for a muscle relaxant, an NSAID, and a short course of tramadol, along with a referral to an orthopedic specialist.

The Liability Dispute That Froze Everything

Within days, the coverage picture turned complicated. The other driver — referred to here as Derek — insisted that the light had been green in his favor and that Maria had run a red. Maria's account was the opposite. There were no traffic cameras at that intersection, and the two eyewitnesses gave conflicting statements. Both drivers had minor property damage claims and their own bodily injury claims.

Derek's insurer, a major national carrier, opened a file but immediately placed liability in dispute. They declined to extend any medical pay coverage for Maria's treatment and sent a reservation-of-rights letter to their own insured. Maria's insurer similarly declined to waive subrogation and refused to advance medical payments while liability remained unresolved.

Maria had no health insurance. She had recently left a job that provided employer coverage and had not yet enrolled in a new plan. Her savings were limited, and a paying retail pharmacy would have required full out-of-pocket payment for her prescriptions — totaling hundreds of dollars per fill, and significantly more once compounding was later introduced for her shoulder.

[!KEY] A pharmacy lien requires no insurance approval, no liability determination, and no up-front payment from the patient. When both carriers are pointing fingers at each other, pharmacy lien access remains entirely unaffected.

Medications on Lien from Day One

Maria's personal injury attorney referred her to LienScripts within the first two weeks of the case. The intake was completed remotely, and she was dispensed her initial prescriptions — cyclobenzaprine 10 mg, naproxen 500 mg, and a muscle-relaxing compound topical for her left shoulder — without any out-of-pocket payment.

Over the following months, her treating orthopedist escalated her regimen after she failed to achieve adequate pain relief with over-the-counter options and standard generics. Gabapentin was added at month two following worsening neuropathic symptoms in her left arm. A lidocaine patch was prescribed for focal shoulder pain at month three. By month four, her physician had introduced a compounded diclofenac/lidocaine cream formulated for deeper tissue penetration.

Maria's pharmacy lien record during the disputed liability phase documented every prescription, every fill date, and the progression of her treatment — building a precise clinical narrative that correlated her medication escalation with her injury trajectory.

Fourteen Months of Litigation Without a Gap in Treatment

Maria's attorney filed suit in the county where the accident occurred. The liability dispute was central to the case. Both sides retained accident reconstruction experts. Depositions were taken from both drivers, the eyewitnesses, and the first responders. The case stretched to fourteen months before both insurers came to the table.

Throughout this entire period — every refill, every new prescription, every medication change — occurred on lien. Maria never paid a dollar out of pocket. She never rationed medications because of cost. She never had to make a decision between pain relief and paying her bills.

The pharmacy lien simply ran parallel to the litigation, documenting treatment as it happened, and waited.

[!KEY] In disputed-liability cases, treatment gaps can be used by defense counsel to argue that the injuries were not serious or were not caused by the accident. Continuous medication records prevent that argument from gaining traction.

The 70/30 Settlement

After fourteen months, both sides agreed to mediation. The accident reconstructionist engaged by Maria's attorney established through skid mark analysis and vehicle damage geometry that the opposing truck had likely entered the intersection approximately 0.4 seconds after the signal changed. The eyewitness who had supported the other driver's account admitted on cross-examination that he had been looking at his phone immediately before the collision and had inferred the signal color rather than directly observed it.

The case settled at mediation on a 70/30 comparative fault allocation — Maria bearing 30 percent of fault, the opposing driver bearing 70. The total settlement figure was reached across both insurers' contributions.

From the gross settlement, Maria's attorney calculated net recovery after deducting the attorney fee. The pharmacy lien balance — representing fourteen months of medications — was then submitted to the settlement administrator. Standard lien reduction negotiations took place between the lien holder and the attorney, consistent with customary practice for liens of that duration. The negotiated lien amount was paid from the net recovery before Maria received her distribution.

Maria later reported that she had been able to maintain her treatment schedule without interruption throughout the case. Her orthopedist noted at final examination that her range of motion had returned to near-baseline, an outcome he attributed in part to consistent medication adherence throughout the recovery period.

Why the Pharmacy Lien Worked Here

This case illustrates several key advantages of the pharmacy lien model in a disputed-liability context.

No dependency on liability. The lien was created between the pharmacy and the patient, secured against the eventual settlement or judgment. The ongoing dispute between the two carriers was entirely irrelevant to Maria's medication access.

Documentation value. Fourteen months of dated pharmacy records, showing a clinically coherent progression from acute injury medications to longer-term pain management, told a compelling story at mediation. Defense counsel could not credibly argue the injuries were minor when the pharmacy records showed consistent escalation by a board-certified orthopedic specialist.

Attorney leverage. Maria's attorney was able to focus entirely on the liability dispute without simultaneously managing a client who was running out of medications or making cost-based treatment decisions. The attorney's negotiating position was stronger because the client's treatment record was complete.

[!KEY] Pharmacy lien records serve dual purposes in disputed-liability cases: they ensure continuous access to treatment, and they generate objective documentation that supports the injury narrative at trial or mediation.

Clean lien resolution at settlement. Because the lien was structured from the outset with clear assignment language, the settlement administrator had a straightforward process for handling the payoff. There were no billing disputes with health insurers, no Medicare secondary payer issues, and no coordination-of-benefits complications.

Related Resources

• What Is a Pharmacy Lien?
• How Pharmacy Lien and Medical Lien Work Together
• Pharmacy Lien — No Out-of-Pocket Explained
• Lien Reduction and Negotiation in Personal Injury
• Soft Tissue Injury Medications on Lien